Inventor
LEE D. ARNOLD
Inventor
US
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds39%
A61KPreparations for medical, dental or toiletry purposes30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%
Y02PClimate change mitigation technologies in the production or processing of goods13%
PatentTitleYear
12,331,039Inhibitors of fibroblast growth factor receptor kinases202512,145,911Inhibitors of cysteine proteases and methods of use thereof202411,814,376Hepatitis b core protein modulators202311,524,940Inhibitors of cysteine proteases and methods of use thereof202211,472,793Inhibitors of cysteine proteases and methods of use thereof202211,390,618Inhibitors of cyclin-dependent kinases202211,345,681Inhibitors of fibroblast growth factor receptor kinases202211,312,704Inhibitors of cysteine proteases and methods of use thereof202211,174,231Inhibitors of cysteine proteases and methods of use thereof2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2024Patents assigned to PARDES BIOSCIENCES INC (5)· patent assignee history
2021–2025Based in US· patent location history
2022Patents assigned to KINNATE BIOPHARMA INC (2)· patent assignee history
2023Patents assigned to ASSEMBLY BIOSCIENCES INC (1)· patent assignee history
2023Patents assigned to UNIV INDIANA RES & TECH CORP (1)· patent assignee history
2025Patents assigned to KHORA SPV 1 LLC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| PARDES BIOSCIENCES INC | 5 | 2021–2024 |
| KINNATE BIOPHARMA INC | 2 | 2022 |
| ASSEMBLY BIOSCIENCES INC | 1 | 2023 |
| KHORA SPV 1 LLC | 1 | 2025 |
| UNIV INDIANA RES & TECH CORP | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 9 | 2021–2025 |